Section Arrow
LNAI.NASDAQ
- Lunai Bioworks Inc.
(Financial Status)
Quotes are at least 15-min delayed:2026/02/07 02:00 EST
Regular Hours
Last
 0.6624
+0.0155 (+2.40%)
Day High 
0.6981 
Prev. Close
0.6469 
1-M High
Volume 
157.03K 
Bid
0.6353
Ask
0.775
Day Low
0.63 
Open
0.6534 
1-M Low
0.6311 
Market Cap 
15.16M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.78 
20-SMA 0.85 
50-SMA
52-W High 1.66 
52-W Low 0.1214 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-7.91/--
Enterprise Value
15.58M
Balance Sheet
Book Value Per Share
-0.56
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
LIMNLiminatus Pharma Inc1.84-0.21-10.24%-- 
RXRXRecursion Pharmaceuticals3.98+0.42+11.80%-- 
FOLDAmicus Therapeutics14.3+0.02+0.14%-- 
ARWRArrowhead Pharmaceuticals64.52-0.12-0.19%-- 
ROIVRoivant Sciences Ltd25.82+4.68+22.14%1.95PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Lunai Bioworks Inc is a biopharmaceutical company. Through its subsidiaries, it is mainly focused on developing allogeneic cell and gene therapies to promote stronger immune system responses, potentially for long-term or life-long cancer remission in some of the deadliest cancers. The group is engaged in the development of RENB-DC11 and RENB-DC20 (potential cell therapeutic vaccine candidates for different types of cancer); a proprietary AI platform that analyzes genetics toprovide earlier and more accurate cancer diagnosis; and machine learning pipelines that harmonize and analyze complex, heterogeneous datasets to uncover clinically actionable insights. The group's reportable segments are: RENB, BioSymetrics, and RENC. Geographically, it operates in the United States and Netherlands.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.